JHS Svendgaard Laboratories Ltd. — Capital/Financing Update 2025

May 17, 2025

==> picture [93 x 69] intentionally omitted <==

CIN : L74110HP2004PLC027558

Date: May 17, 2025

To

The Listing Department The Listing Department Bombay Stock Exchange Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Bandra Kurla Complex Dalal Street, Mumbai – 400001 Mumbai – 400051 Scrip Code: 532771 Trading Symbol: JHS

Subject : Outcome of Meeting of Board of Directors of JHS Svendgaard Laboratories Limited (“the Company”), held on May 17, 2025.

Dear Sir/Ma’am,

In continuation to Board Meeting dated June 04, 2024 and August 03, 2024, we hereby inform you that the Board of Directors of JHS Svendgaard Laboratories Limited ( “the Company” ) at their meeting held today i.e. May 17, 2025, and pursuant to the provisions of the Companies Act, 2013, the relevant SEBI regulations, and other applicable laws, and subject to all necessary approvals, consents, permissions, and sanctions, including approvals of the members of the Company, the Board of Directs of the Company has resolved to vary the objects for the utilization of the proceeds from the Preferential Issue as approved in the Extra-Ordinary General Meeting (EGM) held on July 04, 2024.

It was resolved that the object for the utilization of the proceeds of the preferential issue, amounting to Rs.29,99,99,866.50 (Rupees Twenty Nine Crore Ninety Nine Lakh Ninety Nine Thousand Eight Hundred Sixty Six and Fifty Paise Only), would be revised as follows:

Existing Objects :

==> picture [468 x 149] intentionally omitted <==

----- Start of picture text ----- Sr No. Particulars Total estimated Tentative timelines foramount to be utilized utilization of issue(Rs. In Lakh) * proceeds from the dateof receipt of funds1 For setting up new project in Jammu 2,249.99 By January 15, 2026and Kashmir, under the new IndustrialDevelopment Scheme - 2021-30, J&K,India2 For General Corporate Purpose* 750 By January 15, 2026Total 2,999.99----- End of picture text -----

(*) considering 100% conversion of Warrants into Equity Shares within the stipulated time

==> picture [491 x 62] intentionally omitted <==

==> picture [93 x 69] intentionally omitted <==

CIN : L74110HP2004PLC027558

Note:

• All decimals have been rounded off to two decimal points.

• In terms of NSE Notice No. NSE/CML/2022/56 and BSE Notice No. 20221213-47, dated December 13, 2022, the amount specified for the above-mentioned object of issue size may deviate +/- 10% depending upon the future circumstances

Objects after the proposed amendment:

==> picture [468 x 208] intentionally omitted <==

----- Start of picture text ----- Sr No. Particulars Total estimated Tentative timelines foramount to be utilized utilization of issue(Rs. In Lakh) * proceeds from the dateof receipt of funds1 Fund the capital expenditure for 599.99 By December 15, 2026acquiring equipment for manufacturingfacility2 Infusion of funds in Company’s 1650.01 By December 15, 2026associate entities, i.e. JHS SvendgaardRetail Ventures Ltd. and/or itssubsidiary, for funding the expansionplan through strategic fund infusion.3 For General Corporate Purpose* 749.99 By December 15, 2026Total 2,999.99----- End of picture text -----

• (*) considering 100% conversion of Warrants into Equity Shares within the stipulated time Note:

• All decimals have been rounded off to two decimal points.

• In terms of NSE Notice No. NSE/CML/2022/56 and BSE Notice No. 20221213-47, dated December 13, 2022, the amount specified for the above-mentioned object of issue size may deviate +/- 10% depending upon the future circumstances

The meeting of Board of Directors commenced at 03:41 P.M. and concluded at 04:00 P.M.

This is for your information and records.

Thanking You,

Yours Faithfully,

For JHS Svendgaard Laboratories Limited

KOMAL Digitally signed by KOMAL JHA JHA Date: 2025.05.17 17:27:09 +05'30'

Komal Jha

Company Secretary & Compliance Officer

==> picture [491 x 62] intentionally omitted <==